Erratum to "A proposal of clinical breakpoints for amoxicillin applicable to porcine respiratory tract pathogens" [Vet. Microbiol. 126 (2008) 178-188] (DOI:10.1016/j.vetmic.2007.06.023);A proposal of clinical breakpoints for amoxicillin applicable to porcine respiratory tract pathogens

Veterinary Microbiology

Volumn 126, Issue 1-3, 2008, Pages 178-188

  Schwarz, Stefan ^a   Böttner, Alexander ^b   Goosens, Luc ^c   Hafez, H Mohamed ^d   Hartmann, Katrin ^e   Kaske, Martin ^f   Kehrenberg, Corinna ^a   Kietzmann, Manfred ^f   Klarmann, Dieter ^g   Klein, Günter ^f   Krabisch, Peter ^h   Luhofer, Gabriele ⁱ   Richter, Angelika ^d   Schulz, Bianka ^e   Sigge, Claudia ^j   Waldmann, Karl Heinz ^f   Wallmann, Jürgen ^k   Werckenthin, Christiane ^e  

^a INSTITUT FÜR TIERZUCHT   (Germany)

^b Intervet Innovation GmbH   (Germany)

^c PFIZER INC   (United States)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^g Lebensmittelinstitut Oldenburg   (Germany)

^h TGD Bayern   (Germany)

ⁱ Landesuntersuchungsamt Rheinland Pfalz   (Germany)

^j Bundesverband fur Tiergesundheit BfT   (Germany)

^k Bundesamt F Verbraucherschutz und Lebensmittelsicherheit   (Germany)

more..

Author keywords

Amoxicillin; Antibiotic therapy; Breakpoints; Respiratory diseases; Swine

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; MARBOFLOXACIN; SURAMOX; UNCLASSIFIED DRUG;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; IN VITRO STUDY; MEDICAL LITERATURE; MEDICAL SOCIETY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; SWINE; VETERINARY MEDICINE;

SUIDAE; SUS;

EID: 36749000560     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.07.020     Document Type: Erratum

References (41)

1. Aarestrup F.M., Seyfarth A.M., and Angen Ø. Antimicrobial susceptibility of Haemophilus parasuis and Histophilus somni from pigs and cattle in Denmark. Vet. Microbiol. 101 (2004) 143-146
2. Agerso H., and Friis C. Bioavailability of amoxicillin in pigs. J. Vet. Pharmacol. Ther. 21 (1998) 41-46
3. Agerso H., and Friis C. Penetration of amoxicillin into the respiratory tract tissues and secretions in pigs. Res. Vet. Sci. 64 (1998) 245-250
4. Agerso H., and Friis C. Penetration of amoxicillin to the respiratory tract tissues and secretions in Actinobacillus pleuropneumoniae infected pigs. Res. Vet. Sci. 64 (1998) 251-257
5. Agerso H., Friis C., and Haugegaard J. Water medication of a swine herd with amoxicillin. J. Vet. Pharmacol. Ther. 21 (1998) 199-202
6. Anadon A., Martinez-Larranaga M.R., Diaz M.J., Martinez M.A., Martinez M., Frejo M.T., Tafur M., and Bringas P. Pharmacokinetic and oral bioavailability of amoxicillin in pigs. Proceedings of the Eighth International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT), vol. 66. Jerusalem (2000) 86
7. Anfossi P., Zaghini A., Grassigli G., Menotta S., and Fedrizzi G. Relative oral bioavailability of microgranulated amoxicillin in pigs. J. Vet. Pharmacol. Ther. 25 (2002) 329-334
8. Böttner A., de Jong A., Schmid P., Schüller S., Traeder W., and Weiskopf S. Determination of breakpoints for veterinary medically relevant antibiotics for resistance assessment of veterinary pathogens [in German, with English abstract]. Berl. Münch. Tierärztl. Wschr. 113 (2000) 344-347
9. Burton P.J., Thornberry C., Yee Y.C., Watts J.L., and Yancey Jr. R.J. Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease. J. Vet. Diagn. Invest. 8 (1996) 464-468
10. Bywater R., Silley P., and Simjee S. Antimicrobial breakpoints-definitions and conflicting requirements. Vet. Microbiol. 118 (2006) 158-159
11. Craig W.A. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn. Microbiol. Infect. Dis. 22 (1995) 89-96
12. Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26 (1998) 1-12
13. Deutsches Institut für Normung (DIN) e.V. (Hrsg.): Medizinische Mikrobiologie und Immunologie: diagnostische Verfahren (2000): 3. Auflage, DIN-Taschenbücher, Band 222, pp. 151-294.
14. Gutiérrez-Martín C.B., Garcíá del Blanco N., Blanco M., Navas J., and Rodríguez-Ferri E.F. Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade. Vet. Microbiol. 115 (2006) 218-222
15. Hernandez E., Rey R., Puig M., Garcia M.A., Solans C., and Bregante M.A. Pharmacokinetics and residues of a new oral amoxicillin formulation in piglets: a preliminary study. Vet. J. 170 (2005) 237-242
16. Kadlec K., Kehrenberg C., Wallmann J., and Schwarz S. Antimicrobial susceptibility of Bordetella bronchiseptica isolates from porcine respiratory tract infections. Antimicrob. Agents Chemother. 48 (2004) 4903-4906
17. Kietzmann M., Böttner A., Hafez H.M., Kehrenberg C., Klarmann D., Krabisch P., Kühn T., Luhofer G., Richter A., Schwarz S., Traeder W., Waldmann K.-H., Wallmann J., and Werckenthin C. Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint [in German, with English abstract]. Berl. Münch. Tierärztl. Wschr. 117 (2004) 81-87
18. Marie J., Morvan H., Berthelot-Hérault F., Sanders P., Kempf I., Gautier-Bouchardon A.V., Jouy E., and Kobisch M. Antimicrobial susceptibility of Streptococcus suis isolated from swine in France and from humans in different countries between 1996 and 2000. J. Antimicrob. Chemother. 50 (2002) 201-209
19. Martín de la Fuente A.J., Tucker A.W., Navas J., Blanco M., Morris S.J., and Gutiérrez-Martín C.B. Antimicrobial susceptibility patterns of Haemophilus parasuis from pigs in the United Kingdom and Spain. Vet. Microbiol. 120 (2007) 184-191
20. Martinez-Larranaga M.R., Anadon A., Martinez M.A., Diaz M.J., Frejo M.T., Castellano V.J., Isea G., and de la Cruz C.O. Pharmacokinetics of amoxicillin and the rate of depletion of its residues in pigs. Vet. Rec. 154 (2004) 627-632
21. Matter D., Rossano A., Limat S., Vorlet-Fawer L., Brodard I., and Perreten V. Antimicrobial resistance profile of Actinobacillus pleuropneumoniae and Actinobacillus porcitonsillaris. Vet. Microbiol. 122 (2007) 146-156
22. Morthorst D. Bioavailability of Amoxicillin in Weaning Piglets After Oral and Parenteral Administration by Feed and Water Under Different Conditions [in German, with English Abstract]. Inaugural-Dissertation, Tierärztliche Hochschule Hannover (2002)
23. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Test for Bacteria Isolated from Animals. 2nd ed. (2002), Approved standard M31-A2. NCCLS, Wayne, PA, USA
24. National Committee for Clinical Laboratory Standards (NCCLS). Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents. 2nd ed. (2002), NCCLS document M37-A2. NCCLS, Wayne, PA, USA
25. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Informational Supplement (2004), NCCLS document M31-S1. NCCLS, Wayne, PA, USA
26. Richter A., Böttner A., Goossens L., Hafez H.M., Hartmann K., Kehrenberg C., Kietzmann M., Klarmann D., Klein G., Krabisch P., Kühn T., Luhofer G., Schulz B., Schwarz S., Sigge C., Waldmann K.-H., Wallmann J., and Werckenthin C. Possible causes of failure of antibiotic therapy in veterinary practice [in German, with English abstract]. Prakt. Tierarzt 87 (2006) 624-631
27. Roy O., Hortet P., Houffschmitt P., and Bousquet E. Efficacy of amoxicillin in liquid feed against an Actinobacillus pleuropneumoniae induced pneumonia in pigs. Proceedings of the Eighth International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT), vol. 66. Jerusalem (2000) 66
28. Roy O., Hortet P., Frayssinet L., and Bousquet E. Efficacy of amoxicillin administered into drinking water against an Actinobacillus pleuropneumoniae induced pneumonia in pigs. Proceedings of the Eighth International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT), vol. 66. Jerusalem (2000) 108
29. Schwarz S., Böttner A., Hafez H.M., Kehrenberg C., Kietzmann M., Klarmann D., Klein G., Krabisch P., Kühn T., Luhofer G., Richter A., Traeder W., Waldmann K.-H., Wallmann J., and Werckenthin C. Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications [in German, with English abstract]. Berl. Münch. Tierärztl. Wschr. 116 (2003) 353-361
30. Shryock T.R., White D.W., Staples J.M., and Werner C.S. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretative criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease. J. Vet. Diagn. Invest. 8 (1996) 337-344
31. Sumano H., Ocampo L., Vargas R., and Bousquet E. Pharmacokinetics of three amoxicillin medicated premixes in pigs. Proceedings of the 18th International Pig Veterinary Society (IPVS) Congress, vol. 2 (2004), Hamburg, Germany 538
32. Tanigawa M., and Sawada T. Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae. J. Vet. Med. B 49 (2002) 513-518
33. Tanigawa M., and Sawada T. Exposure time-dependent bactericidal activities of amoxicillin against Actinobacillus pleuropneumoniae; an in vitro and in vivo pharmacodynamic model. J. Vet. Med. B 50 (2003) 436-442
34. Thomas E., Grandemange E., Pommier P., Wessel-Robert S., and Davot J.L. Field evaluation of efficacy and tolerance of a 2% marbofloxacin injectable solution for the treatment of respiratory disease in fattening pigs. Vet. Quart. 22 (2000) 131-135
35. Vela A.I., Moreno M.A., Cebolla J.A., Gonzalez S., Latre M.V., Dominguez L., and Fernandez-Garayzabal J.F. Antimicrobial susceptibility of clinical strains of Streptococcus suis isolated from pigs in Spain. Vet. Microbiol. 105 (2005) 143-147
36. Villa R., Prandin E., Montesissa C., and Silvano C. Serum protein binding of betalactamine derivatives in farm and domestic animals. Proceedings of the Sixth International Congress of Veterinary Pharmacology and Toxicology. Edinburgh, UK (1994) 216-217
37. Wallmann J., Schröter K., Wieler L.H., and Kroker R. Antibiotic sensitivity in selected veterinary pathogens from sick food animals in Germany: results 2001 from the study model of the national antibiotic resistance monitoring [in German, with English abstract]. Tierärztl. Prax. 31(G) (2003) 122-131
38. Wallmann J., Kaspar H., and Kroker R. The prevalence of antimicrobial susceptibility of veterinary pathogens isolated from cattle and pigs: national antibiotic resistance monitoring 2002/2003 of the BVL [in German, with English abstract]. Berl. Münch. Tierärztl. Wschr. 117 (2004) 480-492
39. Wisselink H.J., Veldman K.T., Van den Eede C., Salmon S.A., and Mevius D.J. Quantitative susceptibility of Streptococcus suis strains isolated from diseased pigs in seven European countries to antimicrobial agents licenced in veterinary medicine. Vet. Microbiol. 113 (2006) 73-82
40. Woolcock J.B. Antibiotic susceptibility testing: caeci caecos ducentes. Vet. Rec. 113 (1993) 125-128
41. Yanedt A., Lizarazo V., Rodríguez-Ferri E.F., Martín de la Fuente A.J., and Gutiérrez-Martín C.B. Evaluation of changes in antimicrobial susceptibility patterns of Pasteurella multocida subsp. multocida isolates from pigs in Spain in 1987-1988 and 2003-2004. Am. J. Vet. Res. 67 (2006) 663-668